161 related articles for article (PubMed ID: 17021805)
1. Quantitative detection of the ligand-dependent interaction between the androgen receptor and the co-activator, Tif2, in live cells using two color, two photon fluorescence cross-correlation spectroscopy.
Rosales T; Georget V; Malide D; Smirnov A; Xu J; Combs C; Knutson JR; Nicolas JC; Royer CA
Eur Biophys J; 2007 Feb; 36(2):153-61. PubMed ID: 17021805
[TBL] [Abstract][Full Text] [Related]
2. High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions.
Hua Y; Camarco DP; Strock CJ; Johnston PA
Methods Mol Biol; 2018; 1683():211-227. PubMed ID: 29082495
[TBL] [Abstract][Full Text] [Related]
3. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
Hua Y; Shun TY; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2014 Sep; 12(7):395-418. PubMed ID: 25181412
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.
Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP
Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987
[TBL] [Abstract][Full Text] [Related]
5. Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor.
Song LN; Gelmann EP
J Biol Chem; 2005 Nov; 280(45):37853-67. PubMed ID: 16141201
[TBL] [Abstract][Full Text] [Related]
6. Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen.
Fancher AT; Hua Y; Camarco DP; Close DA; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2016 Oct; 14(8):453-477. PubMed ID: 27606620
[TBL] [Abstract][Full Text] [Related]
7. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region.
Wang Q; Lu J; Yong EL
J Biol Chem; 2001 Mar; 276(10):7493-9. PubMed ID: 11102454
[TBL] [Abstract][Full Text] [Related]
8. High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer.
Fancher AT; Hua Y; Camarco DP; Close DA; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2018; 16(6):297-319. PubMed ID: 30109944
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
[TBL] [Abstract][Full Text] [Related]
11. Testicular zinc finger protein recruits histone deacetylase 2 and suppresses the transactivation function and intranuclear foci formation of agonist-bound androgen receptor competitively with TIF2.
Tao RH; Kawate H; Wu Y; Ohnaka K; Ishizuka M; Inoue A; Hagiwara H; Takayanagi R
Mol Cell Endocrinol; 2006 Mar; 247(1-2):150-65. PubMed ID: 16469430
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
Berrevoets CA; Umar A; Trapman J; Brinkmann AO
Biochem J; 2004 May; 379(Pt 3):731-8. PubMed ID: 14744261
[TBL] [Abstract][Full Text] [Related]
13. Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.
Askew EB; Bai S; Hnat AT; Minges JT; Wilson EM
J Biol Chem; 2009 Dec; 284(50):34793-808. PubMed ID: 19828458
[TBL] [Abstract][Full Text] [Related]
14. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.
Gregory CW; Fei X; Ponguta LA; He B; Bill HM; French FS; Wilson EM
J Biol Chem; 2004 Feb; 279(8):7119-30. PubMed ID: 14662770
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor interactions and dynamics monitored in live cells by fluorescence cross-correlation spectroscopy.
Savatier J; Jalaguier S; Ferguson ML; Cavaillès V; Royer CA
Biochemistry; 2010 Feb; 49(4):772-81. PubMed ID: 20039662
[TBL] [Abstract][Full Text] [Related]
17. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
Agoulnik IU; Vaid A; Nakka M; Alvarado M; Bingman WE; Erdem H; Frolov A; Smith CL; Ayala GE; Ittmann MM; Weigel NL
Cancer Res; 2006 Nov; 66(21):10594-602. PubMed ID: 17079484
[TBL] [Abstract][Full Text] [Related]
18. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs.
He B; Wilson EM
Mol Cell Biol; 2003 Mar; 23(6):2135-50. PubMed ID: 12612084
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
[TBL] [Abstract][Full Text] [Related]
20. Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions.
Black BE; Vitto MJ; Gioeli D; Spencer A; Afshar N; Conaway MR; Weber MJ; Paschal BM
Mol Endocrinol; 2004 Apr; 18(4):834-50. PubMed ID: 14684849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
